Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
Frequently asked questions
What sector does Grape King Bio Ltd (1707) operate in?
Grape King Bio Ltd belongs to the Consumer Staples sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Grape King Bio Ltd (1707) current stock price?
As of the latest data, Grape King Bio Ltd stock price is NT$88.70, with a previous close of NT$89.00. Grape King Bio Ltd lost -NT$0.30 in the last trading session, representing a -0.34% loss.
What is Grape King Bio Ltd (1707) current market capitalization?
Grape King Bio Ltd market cap is approximately 13.14 billion.
What is Grape King Bio Ltd (1707) Earnings Per Share (EPS)?
The trailing EPS is NT$7.86.
What is Grape King Bio Ltd (1707) Price-to-Earnings (P/E) ratio?
Grape King Bio Ltd current P/E ratio is 11.28.
What is Grape King Bio Ltd (1707) EBITDA?
Grape King Bio Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 475.64 million.
Does Grape King Bio Ltd (1707) pay dividends?
No. Grape King Bio Ltd does not pay a dividend.
When is Grape King Bio Ltd (1707) next earnings report?
Grape King Bio Ltd is expected to release its next earnings report on March 31, 2026.
What is Grape King Bio Ltd (1707) beta (volatility) score?
Grape King Bio Ltd has a beta of 0.227, indicating lower volatility than the overall market.
